The Dermatological Lasers Market is expected to surpass US$ 3,487.8 Billion by 2033, Rising Prevalence of Skin Ailments to Drive the Dermatology Lasers Industry: Future Market Insights, Inc.
Increasing Cases of Skin Cancer & Increasing Cosmetic Treatments Fueling Demand for Dermatology Laser Devices. North America is predicted to dominate the dermatology laser products market, accounting for more than 50% of the worldwide value
NEWARK, Del, March 15, 2023 (GLOBE NEWSWIRE) -- Dermatology Lasers Market is expected to grow from US$ 1,767.8 billion in 2023 to US$ 3,487.8 billion in 2033. Dermatology lasers have turned out to be the vital parts of tools owned by dermatologists to treat skin diseases. The WHO states that close to 30% of cancers diagnosed worldwide are skin cancer and nearly 3 Mn non-melanoma skin cancers occur globally all through the year.
The P revalence of S kin P roblems is I ncreasing
Skin disorders and cosmetic issues are accurately targeted and treated with specialized lasers in laser dermatology. The availability of beauty and dermatological laser treatments, rising population spending power, the increased popularity of cosmetic surgery, and the presence of top dermatology laser machine providers are the important factors expected to shape the dermatology laser sector.
The high prevalence of skin cancer is anticipated to impact laser treatment adoption, resulting in increased dermatology laser sales. Furthermore, medical device research and development talents are becoming more prevalent as new healthcare technologies are implemented.
Get a Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12662
The growing elderly population and increasing healthcare infrastructure development expenditures in developing economies are two main factors bolstering the growth of the dermatological lasers market. The industry is experiencing tremendous growth as a result of increased demand in the beauty and personal care sectors, however, some factors are limiting its growth.
The high cost of laser treatment, skin discoloration in some situations, the danger of skin infection, and the heat released by the laser that might permanently damage the retina of the eye are factors affecting the market growth.
Hair removal and face rejuvenation are expected to remain the most popular dermatology laser application areas, owing to increased consumer spending on appearance maintenance.
Key Points from the Dermatology Lasers Market :
The market is expected to surpass US$ 3,487.8 billion by 2033.
Important factors driving market expansion include increased incidences of skin disorders such as psoriasis and vitiligo around the world, which are expected to propel the worldwide market.
The dermatology lasers market is expected to secure a CAGR of 7.0% during the forecast period 2023 to 2033.
North America dominated the dermatology lasers market.
Contact our Market Research Specialist: https://www.futuremarketinsights.com/ask-question/rep-gb-12662
Key Development s in the Dermatology Lasers Market
January 2020 - Nurnberg, Germany, announced the release of the groundbreaking applicator ClearSkin PRO. This product has twice the strength of previous remedies, resulting in skin that seems to be younger.
July 2018 - Candela Corporation reported that its Vbeam Prima, an advanced 595 nm pulsed dye laser, had received FDA approval (PDL). This product includes a new 1,064 nm wavelength as well as other innovative features that can successfully treat a wide range of skin diseases.
February 2021 - POETYK PSO-2, the second pivotal Phase III clinical trial investigating deucravacitinib, a new, selective tyrosine kinase 2 inhibitor for the treatment of patients with moderate to severe plaque psoriasis, was announced by Bristol Myers Squibb Company. POETYK PSO-2 compared deucravacitinib 6 mg once daily to placebo and met both co-primary objectives, with significantly more patients reaching Psoriasis Area and Severity Index (PASI 75).
May 2020 - Dupixent (dupilumab) was approved by the United States Food and Drug Administration (FDA) for the treatment of moderate-to-severe atopic dermatitis.
April 2020 - JUBLIA (efinaconazole) topical solution for the treatment of onychomycosis was approved by the United States Food and Drug Administration (FDA) for Bausch Health Companies Inc. and its dermatology business Ortho Dermatologics.
Key Companies Profiled :
Buy This Report: https://www.futuremarketinsights.com/checkout/12662
Pulsed Dye Lasers
By End User:
Ambulatory Surgical Centres
Dermatology & Cosmetic Clinics
Source: Rising Prevalence of Skin Ailments to Drive the Dermatology Lasers Market, Hitting a Revenue of US$ 2.88 Bn at a Steady CAGR of 7.3% Between the Forecast Period of 2022-30 – Future Market Insights, Inc.
Table of Content
1. Executive Summary | Dermatology Lasers Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
Complete TOC with Report Preview: https://www.futuremarketinsights.com/reports/dermatology-lasers-market
Have a Look at Related Research Reports in the Healthcare Domain:
Generic Injectable Market Size - The global generic injectable market is expected to reach a market valuation of US$ 3,22,433.1 million by the year 2033, accelerating at a CAGR of 11.6% from 2023 to 2033. For the year 2023, the market is set to observe a valuation of US$ 1,07,419.72 million.
Dermatology Lasers Market Growth - The dermatology lasers market is expected to increase at a 7.0% CAGR from 2023 to 2033, from US$ 1,767.8 billion in 2023 to US$ 3,487.8 billion in 2033.
Polyether Ether Ketone (PEEK) Interbody Devices Market Trends - The global polyether ether ketone (PEEK) interbody devices market is to advance at a 7.4% CAGR from 2023 to 2033. Polyether ether ketone interbody device sales are to increase to US$ 4525 million by 2033, from US$ 2207.89 million in 2023.
Cryopreservation for In-vitro Fertilization (IVF) Market Share - The cryopreservation for the in-vitro fertilization market is expected to register a valuation of US$ 461.4 million in 2023. The market is anticipated to rise to US$ 1,264.9 million by 2033. The market is likely to record a CAGR of 10.6% during the forecast period.
Laryngoscopes Market Forecast - The laryngoscope market is set to thrive at a steady CAGR of 5.4% during the forecast period. The market holds a share of US$ 355.1 million in 2023 while it is anticipated to cross a value of US$ 601.6 million by 2033.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S., and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Future Market Insights, Inc.Christiana Corporate, 200 Continental Drive,Suite 401, Newark, Delaware – 19713, USAT: +1-845-579-5705LinkedIn| Twitter| Blogs | YouTubeFor Sales Enquiries: [email protected]The P revalence of S kin P roblems is I ncreasing Get a Sample Copy of the Report: Key Points from the Dermatology Lasers Market : Contact our Market Research Specialist: Key Development s in the Dermatology Lasers Market Key Companies Profiled : Buy This Report: Key Segmentation By Product: By Technology: By Application: By End User: Source: Table of Content 1. Executive Summary | Dermatology Lasers Market 2. Market Overview Complete TOC with Report Preview: Have a Look at Related Research Reports in the Healthcare Domain: About Future Market Insights (FMI) Contact Us: Future Market Insights, Inc.